6Van den Berghe G, Wilmer A, Hermans G,et al. Intensive insulintherapy in the medicai ICU. N Engl J Med, 2006, 349(354):449-461. 被引量：1
7Finfer S, Chittock DR, Su SY, et al. Intensive versus conventionalglucose control in critically ill patients. N Engl J Med, 2009,352(360): 1283-1297. 被引量：1
8Bemaed GR, Vincent JL, Laterre PF, et al. Efficacy and safety ofrecombinant human activated protein C for severe sepsis. N End JMed, 2001,344(10):699-709. 被引量：1
3Annane D, Sebille V, Trocke G, et al. A 3-level prognostic classification of septic shock based on cortisol level and cortisol response to corticotropin[J]. JAMA, 2000, 283(8): 1038-1045. 被引量：1
4Bollaert PE, Charpentier C, Levy B, et al. Reversal of late septic shock with supra physiologic doses of hydroeorlisone [J], Crit Care Med, 1998, 26(4): 645-650. 被引量：1
5Briegel J, Frost H, Hailer M, et al. Stress doses of hydrocorlisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single center study[J]. Crit Care Med, 1999, 27 (4):723-732. 被引量：1
6Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J]. JAMA, 2002, 288(7): 862-871. 被引量：1
7Dellinger P, Carlet JM, Masur H, el al. Surviving Sepsis Campaign guidelines for the management of severe sepsis and septic shock[J]. Crit Care Med, 2004,32(3): 858-873. 被引量：1
8Sprung CL, Annane D, Keh D, et al. The CORTICUS randomized, double-blind, placebo-controlled study of hydrocortisone therapy in patients with septic shock [J]. N Engl J Med, 2008, 358(2): 111-124,. 被引量：1
9Dellinger RP, Levy MM, Cadet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock[J]. Crit Care Med, 2008, 36(1): 296-327. 被引量：1
10Vincent JL. Steroids in sepsis: another swing of the pendulum in our clinical trials [J ]. Crit Care, 2008,12(2): 141-142. 被引量：1
